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Abstract
Study design: Invited narrative review.
Objectives: The aim of this review was to summarize current literature regarding risk factors that surgeons can optimize in the
preoperative setting in the spinal surgery patient, in order to reduce complications and improve patient-reported outcomes.
Methods: Review of the relevant literature by the authors.
Results: Modifiable risk factors identified relative to the patient include obesity, malnutrition/nutrient deficiency, diabetes/
hyperglycemia, preoperative anemia, vitamin D/DEXA (dual-energy radiograph absorptiometry), nicotine use/smoking, and opioid
use/psychosocial factors.
Conclusion: By maximizing a patient’s physiological and psychological status prior to elective spine surgery, we may move closer
to achieving the goals of value-based care: improving patient-reported outcomes while decreasing the cost of care.
Keywords
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Introduction
In recent years, the cost and utilization of spine care both nonoperatively as well as operatively has increased significantly
without documented evidence of improvement in outcomes.1,2
There has been a push recently to shift to a model of valuebased care, with the goal of achieving the highest quality of
care for the least cost rather than simply cutting cost or improving quality alone. This trend has led to a multidisciplinary
approach in the management of spine patients undergoing elective surgery. Additionally, with the change in going from the
fee-for-service compensation model to one of bundled payments for surgical intervention, there is greater pressure on
physicians to lower overall treatment costs. Optimizing
patients preoperatively may lead to improved outcomes and
treatment cost reductions.3,4
This section will examine the recent literature to provide
insight into ways that spine surgeons can optimize surgical
patients in the preoperative setting in an attempt to reduce
complications and ideally improve patient-reported outcomes.
There has been a significant amount of research examining
the use of local and systemic measures to reduce surgical site
infections in spine surgery, including examining procedure-

specific and patient-specific factors.5-8 The use of preoperative
methicillin-resistant Staphylococcus aureus screening, bathing
protocols, wound lavage, and intraoperative vancomycin powder will be discussed in a subsequent section. Modifiable risk
factors relative to the patient, including obesity, malnutrition/
nutrient deficiency, diabetes/hyperglycemia, preoperative anemia, vitamin D/DEXA (dual-energy radiograph absorptiometry),
nicotine use/smoking, and opioid use/psychosocial factors
will be discussed below.

Obesity
The obese represent a challenging patient population to spine
surgeons. In addition to the myriad medical comorbidities
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associated with obesity, such as diabetes, coronary heart disease, and pulmonary disease, obesity in of itself has been
shown to be an independent risk factor for complications associated with spine surgery.9-12 For example, in the Spine Patient
Outcomes Research Trial (SPORT),9 the 4-year follow-up data
demonstrated a high complication profile for obese patients
(infection and revision rates, as compared to nonobese patients)
though similar improvements in patient-reported outcomes in
the surgical group were reported. McGuire et al12 in a subgroup
analysis of the 4-year SPORT data for obese patients, particularly those with BMI >35 kg/m2 (Class II and Class III obesity),
reported worse outcomes in complications, operative time, and
baseline patient-reported outcomes particularly in the degenerative spondylolisthesis group.12 However, Rihn et al 13
demonstrated in a subgroup analysis of obese (BMI >30 kg/m2)
versus nonobese (BMI < 30 kg/m2) undergoing treatment of
lumbar disc herniation that there was no significant differences
in the surgical complication profile between the 2 groups.
When looking solely at patient-reported outcomes based on
the McGuire et al12 and Rihn et al13 studies, there is evidence to
suggest that obese patients do find benefit with surgical interventions despite overall increase in surgical complication profile between nonfusion and fusion operations. These studies as
well as others highlight a complication profile that warrants
appropriate screening and counseling.14,15
Because obesity is a modifiable risk factor, enrolling
patients in a nonsurgical weight loss plan could address this
complex complication profile. Roffey et al16 in a prospective
cohort study with 46 obese individuals employed a 52-week
medically supervised, multidisciplinary, nonsurgical weight
loss program that demonstrated improvements and trends
toward significance in pain scale scores as well as Oswestry
Disability Index (ODI) scores for low back pain and disability.
Although there was no control group, this study highlights that
a nonsurgical weight loss program may have a role in improving functional outcomes for spine patients. There are a few
studies that have examined the role of surgical weight loss and
its effect on minimizing complications in patients undergoing
spine surgery.10,14,17 However, a recent retrospective cohort
study by Jensen et al,10 which looked at reported outcomes
of cervical and lumbar surgery, demonstrated that patients who
had undergone bariatric surgery had worse reported outcomes
and satisfaction following lumbar surgery than their counterparts. We have a paucity of data to guide us regarding nonsurgical or surgical weight loss, and further studies are necessary
to suggest one intervention over the other. The focus must be
placed on minimizing the associated medical risk factors associated with obesity and focus on potential nonsurgical weight
loss to improve outcomes in the perioperative setting.

Malnutrition/Nutrient Deficiency
In the orthopedic and neurosurgery literature, we have interchangeably used serological markers such as albumin,
pre-albumin, transferrin, and total lymphocyte count to define
malnutrition. Albumin levels <3.5 g/dL, serum total
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lymphocyte count <1500 cells per cubic millimeter, low prealbumin levels, and/or transferrin levels <200 mg/dL have been
shown to be signs of malnutrition and have been harbingers of
increased complications such as wound healing and surgical
site infections.11,18-22 Kudo et al23 in a retrospective analysis
of over 100 patients examined the effect of the rapid turnover
proteins (pre-albumin and transferrin) and the ability to predict
surgical site infections. In this study, pre-albumin, transferrin,
and albumin levels alone did not demonstrate statistical significance in predicting surgical site infection using multivariate
analysis. However, in their univariate analysis there was statistical significance reached for those variables suggesting a possible role in predicting surgical site infections.
The most widely used markers in the literature appear to be
serum albumin and total lymphocyte count as markers of malnutrition, and subsequently, these markers have been utilized to
screen patients who are at risk for perioperative complications.24-27
If patients undergoing elective spine surgery have laboratory or serum markers that fall below normal values or below
the thresholds outlined above, then a nutritional consult is warranted. In the setting of elective spine surgery, nutritional deficiencies may be addressed preoperatively to reduce the overall
complication profile and potentially minimize risk of surgical
site infections. In trauma or oncologic cases, these markers can
be utilized to predict which individuals may be at higher risk of
surgical site infections.

Diabetes/Hyperglycemia
Similar to obesity, diabetes and hyperglycemia have been
shown to be independent risk factors for increased surgical
complications.28-30 It is believed that diabetes and/or hyperglycemia causes impaired oxygen delivery via the glycosylation of
hemoglobin, which leads to the downstream effect of tissue
ischemia. The disruption of glucose utilization has been shown
to increase the risk of surgical site infections in orthopedic
surgery.31,32 As in obesity, individuals with diabetes are more
likely to have additional medical comorbidities that affect surgical outcomes.28,33-35 In addition to increased complication
profile for diabetic patients, studies have suggested increased
cost associated with the perioperative management of diabetic
patients. Underwood et al,36 using National Surgical Quality
Improvement Program (NSQIP) database as well as patient
registry data determined that preoperative A1C above 8%
demonstrated increased length of stays and complications.
Walid et al 37-39 have demonstrated in several papers the
increased cost associated with diabetes and other comorbidities
across patients undergoing spine surgery and has advocated for
the use of glycated hemoglobin (A1C) as screening tool.
Perioperative hyperglycemia has been noted to have an
additive effect on patients undergoing the stress of surgery.
Modulation of the stress response, specifically the
hypothalamic-pituitary-adrenal axis as well as sympathetic nervous system, are often disrupted in the setting of diabetes or
hyperglycemia as shown in critically ill patients.40-42 In the
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orthopedic literature it has been established that diabetes
increases the complication profile for those undergoing elective total joint arthroplasty.43,44
Careful coordination and appropriate cardiovascular risk
stratification in patients with diabetes is also warranted. The
Clinical Guidelines Committee from the American College of
Physicians has recommended an insulin infusion to maintain
glucose levels <200 mg/dL with a maintenance goal in the
range of 140 to 180 mg/dL for critically ill patients.45 However,
in the perioperative period, patients with relatively wellcontrolled blood sugars can be transitioned or managed with
subcutaneous or supplemental insulin therapy (ie, insulin sliding scale) to maintain blood sugars in the 140 to 200 mg/dL
range particularly if they are being transitioned to enteral nutrition and receiving appropriate intravenous fluids (often dextrose solution, 5%, with either normal or half normal saline).
The utilization of an insulin sliding scale is a corrective method
of treating hyperglycemia and can lead to continued variability
in point of care blood sugars. The initiation of proactive measures such as placement on basal or bolus insulin may be more
effective in the management of inpatient hyperglycemia.46
Appropriate preoperative screening with A1C and maintaining tight hyperglycemic control in the perioperative setting can
effectively minimize complications and ultimately costs for
elective spine procedures.

Anemia
It has been well established that preoperative anemia, defined
as hematocrit <38%, or hemoglobin less than 12 g/dL (<13 g/dL
for men), has been associated with increased rates of transfusion and perioperative morbidity and mortality47-53 during
various non-cardiac procedures. Seicean et al,47 using the
American College of Surgeons NSQIP database, demonstrated that those individuals with anemia, regardless of the
severity, had increased lengths of stay during their hospitalization and were more likely to experience complications and
30-day mortality compared to propensity-matched patients
without anemia.
Guinn et al54 implemented an anemia screening and treatment
pathway for patients undergoing elective joint arthroplasty. In
their study, patients who were indicated for surgery and found to
be anemic using a point-of-care hemoglobin analyzer were
placed in a pathway to manage their anemia. This pathway
included obtaining labs to identify sources of anemia and
included a complete blood cell count, basic metabolic panel,
iron studies (ferritin, iron, iron saturation, total iron binding
capacity, and reticulocyte count), B12 level, and folate. Depending on the results of the labs, patients had planned surgeries
delayed in order to obtain appropriate medical referrals and to
initiate treatment of anemia prior to scheduled surgery. Interventions included either IV iron infusions or PO iron supplementation or use of erythropoietin.54 The results of this study identified
25 at-risk patients for anemia of which only one patient required
perioperative transfusion. Blood management goals for patients
undergoing surgery should include minimizing blood loss
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intraoperatively, as well as screening for and treating anemia
to increase red blood cell mass. The effective screening of and
treatment of perioperative anemia can lead to decreased lengths
of stay and potentially transfusion avoidance, which can lower
morbidity and mortality in the long run.

Vitamin D/DEXA:
With the increasing prevalence of osteoporosis in our aging
population, there remains concern for bone-implant failures
in patients undergoing elective spinal fusion procedures. Vitamin D is a fat-soluble steroid that facilitates the absorption of
dietary calcium and phosphate. Typically, vitamin D insufficiency or deficiency stems from lack of exposure to sunlight or
abnormal intestinal absorption. Screening for and treating vitamin D deficiency entails obtaining serum 25-hydroxyvitamin D
(25OHD) and supplementing as necessary. Typically, this
involves 50 000 IU of vitamin D orally weekly for upwards of
8 weeks.55 In a meta-analysis, Bischoff-Ferrari et al56 demonstrated a reduction in pooled fracture risk with 800 IU of vitamin D daily. The addition of 1200 mg of calcium to the 800 IU
of vitamin D was also shown to reduce fracture risk, particularly those over 50 years of age.57
In a review of over 300 patients undergoing spinal fusion
that were screened for vitamin D levels, 27% were found to be
deficient. The vitamin D–deficient patients were more likely to
be obese and report greater disability on their outcomes.58 In
another study, patients with vitamin D deficiency (serum 25
OH levels < 20 ng/mL) undergoing elective spine surgery were
found on multivariate analysis to have a higher risk of nonunion (odds ratio 3.449).59
When deciding on screening for osteoporosis, the DEXA
scan is the standard used by the World Health Organization.
Osteoporosis is defined by a T score of < 2.5, or greater than
2.5 standard deviations below, optimal bone mineral density. A
DEXA scan, in addition to other patient-specific factors, can be
used to estimate an individual’s 10-year probability risk of
major fracture by using a computer-based algorithm (ie, FRAX
score).60 Osteoporosis of the spine can pose a challenge for the
spine surgeon when considering instrumentation. Although
animal studies have demonstrated that treatment of osteoporosis with anti-resorptive drugs (bisphosphonates) or with anabolic agents such as teriparatide have improved radiographic
signs of fusion, clinical trials have not shown clinically significant reduction in complications or patient-reported outcomes.61 Regardless, it remains important for the practicing
spine surgeon to ensure that elective fusion/instrumentation
patients have been screened appropriately to prevent possible
failures due to poor bone-implant characteristics.62 Bjerke
et al63 demonstrated, in a retrospective cohort of 140 patients
undergoing thoracolumbar fusion, increased osteoporosisrelated complications (ie, failure of instrumentation, proximal
junctional kyphosis/failure, and pseudarthrosis) in individuals
with osteopenia and osteoporosis compared to those with normal bone density. The authors inferred increased risk of failure
or poor outcomes T scores < 1.0.
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Patients with a T score of < 2.5 should be approached
cautiously when instrumentation is being considered, especially in multilevel fusion constructs. We recommend supplementing with vitamin D and calcium as well as using an
anabolic agent such as teriparatide for 3 months preoperatively
and continuing for 1 to 2 years postoperatively to limit the
potential for complications in this subgroup of patients.

Nicotine
The deleterious effects of smoking are well established by not
only the World Health Organization but the American Cancer
Society as well. Smoking negatively affects soft tissue perfusion, wound healing, spinal fusion, and the ability of our
immune system to fight pathogens.64-69
Screening for smoking history is the first step in helping
improve patient outcomes. Once a patient has been identified
as an active smoker, implementing a successful cessation pathway can be challenging. Nicotine replacement therapy (either
with transdermal patches or chewing gums), self-help, and
counseling have been utilized to improve the success rate of
individuals wishing to quit.70 Frequent counseling by health
care providers as part of a smoking cessation program has also
been shown to be clinically effective and can provide an opportunity for the surgeon to intervene.71 Unfortunately, these
resources may be scarce in the underinsured or Medicaid populations. Nonetheless, it is imperative to have a frank discussion
with patients regarding the risks of continued cigarette smoking
and its associated complications pertaining to spine surgery.72-74
Studies have not only demonstrated the increased risk of perioperative complications of smoking and/or nicotine use, but
even more significant is how smoking can effect functional
outcomes and patient-reported outcomes.68,75,76 For example,
Pearson et al76 utilizing a subgroup analysis of the SPORT
data demonstrated that smokers undergoing decompressive
intervention without fusion had no statistical clinical difference in outcomes compared to the nonoperative treatment
cohorts. This implies that smoking cessation may lead to
improved patient-reported outcomes.
As far as determining duration of cessation and effects on
patient-reported outcomes, there are no prospective studies
demonstrating the ideal time for cessation or duration of cessation during the perioperative period. Glassman et al,68 in a
retrospective study of 357 patients, demonstrated that there
were no differences between postoperative satisfaction scores
and the length of preoperative smoking cessation; however, in
patients who were able to remain compliant with smoking cessation in the postoperative period there was a trend toward
improved patient satisfaction despite no statistical significance.
Every attempt should be made by the spine surgeon to counsel their patients on the perioperative complications and provide the resources/referrals necessary to begin smoking
cessation at least a month prior to elective surgery, knowing
full well that continuing to provide support for smoking cessation postoperatively may need to extend well past 3 months
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postoperatively not only for surgery-related outcomes, perhaps
just as important regarding patient-reported outcomes.

Opioids and Psychosocial Factors
Spine surgery is physically and psychologically stressful for
patients. The ability of patients to cope with these demands
varies.77,78 Often, our patients have a history of depression
and/or anxiety and are taking psychoactive medications. Moreover, these individuals often have a long history of opioid use.
Such patients require a diligent review for factors affecting
their perioperative risks. Hu et al79 describes utilizing a clinical
pharmacist for adult spinal deformity patients in the preoperative setting to ensure that the appropriate medications are held
preoperatively, and that the appropriate IV morphine equivalents are utilized postoperatively, to minimize the risks of additive side effects from poly-pharmacy.
Patients undergoing elective spine surgery have been shown
to be at increased risk of opioid dependence.80 Despite the rise
in consumption of opioids in the management of pain, their use
has not been substantiated in improving patient-reported outcomes particularly after spine surgery.81 Hills et al81 reported
1-year outcome data on over 2100 patients undergoing spine
surgery, of which 21% of their cohort were on chronic opioid
therapy. This subset of patients had higher adjusted odds ratios
of continued pain, 90-day complications, and continued postoperative opioid use. More troubling is that opioid abuse and
dependence places our patients at increased risk for all-cause
morbidity as well as inpatient mortality.80
Understanding risk factors and the complication profile of
opioid use in our patients is paramount to implementing a pathway to improve not only perioperative surgical outcomes but
patient-reported outcomes as well. Studies have demonstrated
that opioid use within 6 months of surgery persists in the postoperative period, and the utilization of resources adds continued cost to our medical system.82,83 Higher opioid use, as
measured using morphine equivalents, is associated with
increased hospital length of stay as well as significantly worse
patient-reported outcomes following spine surgery. 84,85
Patients taking larger doses of opioids, greater than 10 mg of
morphine equivalents per day, should be cautiously approached
when recommending surgery. Involving Pain Management
practitioners to assist with patient-specific regimens and reducing morphine equivalents prior to surgery may have benefit.
Mental health plays a significant role in the perception of
pain and functional outcomes; moreover, it has been shown that
depression and/or anxiety are closely associated with preoperative opioid or chronic opioid use.84-89 It is imperative as a
surgeon to ensure that patients understand the expectation of
minimizing chronic opioid use in the perioperative period,
which may be accomplished with the assistance of a pain management physician who can set expectations for postoperative
opioid consumption. A significant number of patients presenting to spinal surgeons have psychological disorders that may
affect their outcomes. Surgeons’ ability to detect mental health
issues alone is variable.90-92 A routine psychological screening
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Table 1. Patient-Specific Factors for Minimizing Complications in Spine Surgery.
Goals
Body mass index

Interventions if Goals Not Met

<35 kg/m2

Nutrition referral/diet and exercise program; consider bariatric consult
if class III obesity
Serum albumin
>3.5 g/dL
Nutrition referral
Hemoglobin A1c
<7%
Endocrinology referral
Hemoglobin
>12 g/dL for women and >13 g/dL for men Hematology referral, anemia workup
Vitamin D (25OHD) >30 ng/mL
Endocrinology referral; initiate supplementation: 50 000 IU vitamin D weekly
DEXA
T score > 2.5 (ideally > 1.0)
Endocrinology referral; consider vitamin D/calcium supplementation versus
anti-resorptive versus anabolic bone modulators
Morphine
<10 mg/day
Pain management referral, possible behavioral therapy
equivalents
Nicotine
Nonsmoking
Smoking cessation, cognitive-behavioral therapy, pharmacological
intervention
Abbreviations: 25OHD, 25-hydroxyvitamin D; DEXA, dual-energy radiograph absorptiometry.

questionnaire may be helpful in detecting patients that may
need counseling prior to surgical intervention.93,94 Miller
et al95 utilized the Patient Health Questionnaire–9 (PHQ-9)
in over 900 patients undergoing various lumbar procedures and
determined that the higher the PHQ-9 score (increased likelihood of depressive disorder), the more likely the minimally
clinically important difference for EuroQoL-5D (EQ-5D)
would not be met (odds ratio of 0.93). Merrill et al96 was able
to utilize patient-reported outcome measures (PROMIS physical function, pain, physical function, and ODI) in a retrospective cohort for 55 patients undergoing decompression alone and
noted the depressed cohort (PROMIS depression score >50)
had worse postoperative PROMIS physical function, pain, and
ODI scores. In other words, patients who were depressed did
have significant improvement following surgical intervention,
and although these individuals had a greater magnitude of
improvement compared to the nondepressed cohort, they overall had worse physical function, pain, and ODI scores at
6 months than those who were not depressed.
Appropriate recognition and screening of our patients for
opioids and depression can ultimately improve patientreported outcomes. Working closely with our mental health
and pain management colleagues can also help facilitate
improved functional outcomes in this challenging patient
population.

Conclusion
Optimizing patient outcomes in patients undergoing spinal surgery requires an awareness of the multitude of preoperative
factors that have been shown to affect our patients’ health and
their ability to heal and recover from spinal surgery (Table 1).
Reducing predictable complications through appropriate
patient screening preoperatively can improve surgical as well
as patient-reported outcomes. Providing our patients with the
best surgical and functional outcomes involves an integrated
multidisciplinary practice. By maximizing a patient’s physiological and psychological status prior to elective spine surgery,
we may move closer to achieving the goals of value-based care:

improving patient-reported outcomes while decreasing the cost
of care through perioperative risk reduction.
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